Anne Alaniz — Houston Methodist Scholars

If you made any changes in Pure these will be visible here soon.

Education/Academic qualification

MD, University of North Texas Health Science Center, 12376, School of Public Health, Fort Worth, Texas, United States.

5 Active
10 Not started

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
Zaid, T., Alaniz, A., Coffey, D., Singh, M. & Suri, A.
6/22/22 → …
Project: Clinical Trial
GOG-3044 LAE002INT2001
Kamat, A. A., Alaniz, A., Singh, M., Suri, A. & Zaid, T.
4/16/21 → …
Project: Clinical Trial
An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-ResistantOvarian Cancer
Kamat, A. A., Alaniz, A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.
3/15/21 → 3/14/46
Project: Non Profit
A Phase II Trial of Ribociclib (LEE011) Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube or Peritoneum (GOG-3026)
Kamat, A. A., Alaniz, A., Singh, M., Suri, A. & Zaid, T.
12/19/19 → …
Project: Clinical Trial
A phase III, multicenter, randomized, study of atezolizumab/placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer
Kamat, A. A., Alaniz, A., Bernicker, E. H., Darcourt, J., Heyne, K., Singh, M., Suri, A. & Zaid, T.
3/13/18 → 3/12/43
Project: Non Profit